Clinical trial
A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)
NCT06271538 is registered in ClinicalTrials.gov with EP Plus Group Sdn Bhd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)
- Lead sponsor
- EP Plus Group Sdn Bhd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 17, 2024
- Completion date
- April 14, 2026
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colonic disease, colonic diseases, functional, digestive system disease, disease, gastrointestinal diseases, intestinal disease, irritable bowel syndrome, pathologic processes